From: Development of a pharmacoeconomic registry: an example using hormonal contraceptives
Author, year, country and reference | Perspective | Cost of unintended pregnancy, millions (US$, 2020)b | % attributed to imperfect adherence |
---|---|---|---|
Trussell, 2013 (USA) [80] | Third party health care payer | 5426 | 53% |
Trussell, 2007 (USA) [81] | Payer | 7056 | NA |
Henry, 2015 (Norway) [77] | Societal | 42 | 60.40% |
Engstrand, 2018 (Sweden) [78] | Societal | 117 | 61.40% |
Montouchet, 2013 (UK) [82] | NHS | 330 | NA |
Lete, 2015 (Spain) [83] | Spanish National Health System | 483 | 69% |
Le, 2015 (South Africa) [79] | Payer | 675a | NA |
Black, 2015 (Canada) [84] | Public payer | 293 | 69% |
Lowin, 2015 (Russia) [85] | Generic payer | 898 | NA |
Dieguez, 2015 (USA) [86] | Employer-Sponsored health insurance plans | NA | NA |